Xtant Medical Holdings
Stock Forecast, Prediction & Price Target
Xtant Medical Holdings (XTNT) stock Price Target by analysts
$1.5
Potential upside: 130.76%
Xtant Medical Holdings price prediction
What is Xtant Medical Holdings stock analysts` prediction?
Xtant Medical Holdings stock forecast: Based on 1 Wall Street analysts` predicted price targets for Xtant Medical Holdings in the last 3 months, the avarage price target is $1.5, with a high forecast of $NaN. The average price target represents a 130.76% change from the last price of $0.65.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Xtant Medical Holdings stock Price Target by analysts
Full breakdown of analysts given Xtant Medical Holdings price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Chase Knickerbocker Craig-Hallum | 0% 0/1 | 11 months ago | $1.5 130.76% upside | $0.56 | StreetInsider | Previous targets (0) |
Xtant Medical Holdings Financial Estimates
Xtant Medical Holdings Revenue Estimates
Xtant Medical Holdings EBITDA Estimates
Xtant Medical Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $55.26M N/A | $57.96M 4.89% | $91.30M 57.50% | Avg: $134M Low: $128.3M High: $139.7M avg. 46.76% | Avg: $163.1M Low: $159.37M High: $166.82M avg. 21.71% | ||
Net Income
% change YoY
| $-5.84M N/A | $-8.48M -45.19% | $660K 107.77% | Avg: $-1.5M Low: $-1.30M High: $-1.23M avg. -327.27% | Avg: $4M Low: $3.69M High: $3.91M avg. 366.66% | ||
EBITDA
% change YoY
| $-2.52M N/A | $-5.43M -115.38% | $5.07M 193.42% | Avg: $-4.79M Low: $-4.99M High: $-4.58M avg. -194.38% | Avg: $-5.83M Low: $-5.96M High: $-5.69M avg. -21.71% | ||
EPS
% change YoY
| -$0.07 N/A | -$0.09 -31.87% | $0.01 106.09% | Avg: -$0.01 Low: -$0.01 High: -$0.01 avg. -281.81% | Avg: $0.03 Low: $0.03 High: $0.03 avg. 400% | ||
Operating Expenses
% change YoY
| $36.34M N/A | $38.89M 7.01% | $65.62M 68.73% | Avg: $89.09M Low: $85.30M High: $92.88M avg. 35.76% | Avg: $108.44M Low: $105.97M High: $110.92M avg. 21.71% | ||
FAQ
What is Xtant Medical Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 19.69% in 2025-2026.
We have gathered data from 2 analysts. Their low estimate is -1.30M, average is -1.5M and high is -1.23M.
What is Xtant Medical Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 34.24% in 2025-2026.
We have gathered data from 2 analysts. Their low revenue estimate is $128.3M, average is $134M and high is $139.7M.
What is Xtant Medical Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 59.09% in 2025-2026.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.01, average is -$0.01 and high is $-0.00.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Xtant Medical Holdings stock. The most successful analyst is Chase Knickerbocker.